Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00177437 · ClinicalTrials.gov registry record · Phase 3
Home Screening for Chlamydia Surveillance
A Phase 3 study of Gonorrhea and Chlamydia Trachomatis, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 3
- Development phase
- 403
- Enrollment target
- 1
- Study location
NCT00177437: Completed Phase 3 study of Gonorrhea and Chlamydia Trachomatis, sponsored by University of Pittsburgh.
NCT00177437 is a Phase 3 study of Gonorrhea and Chlamydia Trachomatis that has completed, run by University of Pittsburgh. The registered enrollment target is 403 participants, below the 1,405-participant average among 10 other Gonorrhea trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00177437, a Phase 3 study of Gonorrhea and Chlamydia Trachomatis, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 403 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized controlled trial to determine whether a home screening test for chlamydia and gonorrhea will lead to increased use of screening tests and increased detection of sexually transmitted diseases.
Conditions Studied
Interventions
- BEHAVIORAL home testing kit
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 403 participants |
| Start Date | 1999-06 |
| Est. Completion | 2005-09 |
| Phase | Phase 3 |
What the finished NCT00177437 record still lists
NCT00177437 is an interventional study that assigns participants to a tested intervention. The registered 403 participants enrollment target is mid-sized for trials with a published cap, below the 1,405-participant average among 10 other Gonorrhea trials with a reported enrollment target (71% lower).
The record links to 2 conditions, with Gonorrhea appearing as the primary indexed condition, and to 1 intervention - of which home testing kit is the first listed.
NCT00177437 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00177437 about?
NCT00177437 is a clinical study titled "Home Screening for Chlamydia Surveillance". This is a randomized controlled trial to determine whether a home screening test for chlamydia and gonorrhea will lead to increased use of screening tests and increased detection of sexually transmitted diseases.
What is the current status of trial NCT00177437?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 403 participants. The study started on 1999-06. Estimated completion is 2005-09.
What conditions does trial NCT00177437 study?
This clinical trial studies the following conditions: Gonorrhea, Chlamydia Trachomatis.
What interventions are being tested in trial NCT00177437?
The interventions under investigation include: home testing kit (BEHAVIORAL).
Who is sponsoring clinical trial NCT00177437?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00177437 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gonorrhea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00177437's enrollment target sits among peer trials
403 4th of 10 higher than 7 of 10 other Gonorrhea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gonorrhea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea
COMPLETED · Phase 3
-
Effectiveness of Relationship Education for Reducing HIV Incidence Among SGM
RECRUITING · NA
-
Assessing Acceptability and Feasibiity of STI Self-swab Testing, to be Offered at the Time of Telemed Medication Abortion Provision
RECRUITING · NA
-
Online HIV Prevention for Young Male Couples
COMPLETED · Phase 2
-
A Dose-Ranging Study Evaluating the Efficacy, Safety, and Tolerability of GSK2140944 in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae
COMPLETED · Phase 2
-
Zenyth: Motivational Interviewing-based Telehealth Intervention for Bacterial Sexually Transmitted Infection Screening
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05647122 · 403 participants · Phase 1
First in Human Study of AZD9592 in Solid Tumors
- NCT05674799 · 403 participants · NA
NDPP-NextGen: A Clinical Trial to Reduce Intergenerational Obesity and Diabetes Risks
- NCT06244771 · 403 participants · Phase 1
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
- NCT05049057 · 404 participants · Phase 2
Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia